recurrent breast cancer treatment
Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer
... additional treatment costs can lead to such a situation ...A treatment may just be too expensive because it is linked to other additional costs which cannot be offset by cost ...
27
Re-irradiation for locally recurrent refractory breast cancer
... radiotherapy treatment that involved definitive or aggressive palliative re-irradiation to the breast/chest wall +/- regional lymph ...confirmed recurrent breast cancer and had been ...
12
Radiotherapy and Hyperthermia in the Treatment of Locoregional Recurrent Cancer-Report of the First Patients Treated in Portugal
... the treatment of locoregional recurrence of previously irradiated malignant ...the treatment of these lesions, reporting the first cases treated in Portugal with this therapeutic ...treatments. ...
5
Expression and clinicopathological significance of fsip1 in breast cancer
... primary breast cancer (mean age: ...with recurrent and metastatic breast cancer (mean age: ...primary breast cancer, no mastectomy, breast- conserving surgery or ...
9
EuropePMC-PMC5540165.pdf
... locally recurrent breast cancer, but the competing medical conditions that are more likely to impact survival, similar to other treatment and screening ...older breast cancer ...
16
Successful Treatment of Recurrent Triple Negative Breast Cancer with Combination of Targeted Therapies
... initial treatment included lumpectomy, TAC chemotherapy (six cycles of docetaxel, doxorubicin, and cyclophosphamide), reexcision, and radiation therapy, through September 2, 2007, which resulted in complete ...
5
A case of HER 2 positive recurrent breast cancer showing a clinically complete response to trastuzumab containing chemotherapy after primary treatment of triple negative breast cancer
... invasive breast cancer ...systemic treatment for recurrent and metastatic breast cancer is based on the ER, PgR, and HER-2 status of the primary ...metastatic breast ...
5
BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis
... The effect of BRCA1 mutation on outcomes of BC patients may differ from BRCA2 mutation as a result of different molecular mechanisms of tumorgenesis. Although the specific molecular mechanisms are unclear currently, ...
15
Nutritional, therapeutic, and pharmaceutical potential of plant gums: A review
... drug release. These polysaccharide based encapsulation and targeted delivery systems are envisaged to have an immense potential for the development of food/nutraceutical formulations for colon-based diseases, including ...
19
The influence of tamoxifen on normal mouse mammary gland homeostasis
... To determine the effects of tamoxifen on the mammary glands of adult mice, 10– to 14-week-old C57BL/6 J mice were given a single IP injection of 0.2 mg, 1 mg, or 5 mg tamoxifen (dissolved in 100% corn oil), or three IP ...
11
Detection of C Reactive Protein level in breast cancer
... 7. Bodour S, Coya T, Elia AI, et al. Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology. BMC Women?’?s Health. 2011;11:44. 8. Cynthia AT, ...
12
He kupenga mate pukupuku uu mo ngā wāhine Māori : Te Whare Tapa Whā : a multidimensional exploration of the impacts of breast cancer among wāhine Māori survivors : a thesis presented in partial fulfilment of the requirements for a Master of Philosophy in Māori Studies at Massey University, Palmerston North, New Zealand
... This multidimensional exploration of how breast cancer impacts on the well-being of Māori women uses Te Whare Tapa Whā (Durie, 1994) to capture the aspects of well -being in a Māori context. The objective ...
12
Breast Cancer and Herbal Treatment
... in breast cancer-Most commonly used herbs to treat breast cancer includes echinacea, St John’s wort, green tea and ginger,curcuma, the herbs such as Vin- ca rosea, Taxus species, Allium ...
11
Acceptance and expectations of an App for physical activity in breast cancer patients : exploring the feasibility of implementing and using the Pinktrainer during breast cancer treatment in outpatient setting at Ziekenhuisgroep Twente : combining the perspectives of patients and health care professionals
... 43 cancer patients (Baseline measurements) and Appendix VII Pilot ...Pinktrainer treatment from demonstration to full use in practice, for which the NASSS framework provides a complete framework to develop ...
157
Aim To study the spectrum of breast lesions. Methods Breast Lump is the commonest presenting symptom in various types of Breast lesions ranging
... 50% to 95% depending on the experience of the aspirator and the interpreter. [2] The current study was carried out with aim of studying the frequency of various breast lesions on FNAC in Department of Pathology, ...
7
Free radial forearm flap after partial glossectomy for squamous cell carcinoma of the tongue
... suggests breast cancer patients suffered im- pairments of the upper limb, even at one year after operation and many experiencing limited activities of daily living with negative impact on quality of ...
46
Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment
... to breast cancer prognosis. The precise role and treatment strategies to target macrophages remain ...four breast cancer cell lines (MCF7, T47D, MDA-MB-231, MDA-MB-468) to model in vivo ...
13
Bilateral mammoplasty for cancer: Surgical, oncological and patient-reported outcomes.
... neoadjuvant treatment. Surgical technique for each breast and timing of contralateral symmetrisation, nipple-areola complex removal and either immediate or delayed nipple reconstruction were ...(index ...
21
Breast reconstruction
... of breast reconstruction. Immediate breast reconstruction, performed during the same procedure as oncologic resection, has the distinct advantages of decreasing the total number of surgeries, providing ...
9
Current approaches to the management of Her2 negative metastatic breast cancer
... rst-line treatment of Her2-negative MBC has recently undergone considerable ...for Breast Oncology ), and TRIO-10 (Translational Research In Oncology), which evaluated the addition of bevacizumab to ...
14